{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:51:50Z","timestamp":1777960310179,"version":"3.51.4"},"reference-count":126,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/NAN-MAT\/1431\/2021"],"award-info":[{"award-number":["PTDC\/NAN-MAT\/1431\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["2021.08095.BD"],"award-info":[{"award-number":["2021.08095.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Coronavirus disease-19 (COVID-19) emerged in December 2019 and quickly spread, giving rise to a pandemic crisis. Therefore, it triggered tireless efforts to identify the mechanisms of the disease, how to prevent and treat it, and to limit and hamper its global dissemination. Considering the above, the search for prophylactic approaches has led to a revolution in the reglementary pharmaceutical pipeline, with the approval of vaccines against COVID-19 in an unprecedented way. Moreover, a drug repurposing scheme using regulatory-approved antiretroviral agents is also being pursued. However, their physicochemical characteristics or reported adverse events have sometimes limited their use. Hence, nanotechnology has been employed to potentially overcome some of these challenges, particularly cyclodextrins. Cyclodextrins are cyclic oligosaccharides that present hydrophobic cavities suitable for complexing several drugs. This review, besides presenting studies on the inclusion of antiviral drugs in cyclodextrins, aims to summarize some currently available prophylactic and therapeutic schemes against COVID-19, highlighting those that already make use of cyclodextrins for their complexation. In addition, some new therapeutic approaches are underscored, and the potential application of cyclodextrins to increase their promising application against COVID-19 will be addressed. This review describes the instances in which the use of cyclodextrins promotes increased bioavailability, antiviral action, and the solubility of the drugs under analysis. The potential use of cyclodextrins as an active ingredient is also covered. Finally, toxicity and regulatory issues as well as future perspectives regarding the use of cyclodextrins in COVID-19 therapy will be provided.<\/jats:p>","DOI":"10.3390\/ijms24032974","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T02:35:10Z","timestamp":1675391710000},"page":"2974","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Role of Cyclodextrins in COVID-19 Therapy\u2014A Literature Review"],"prefix":"10.3390","volume":"24","author":[{"given":"Beatriz","family":"Almeida","sequence":"first","affiliation":[{"name":"Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8432-9839","authenticated-orcid":false,"given":"C\u00e1tia","family":"Domingues","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"LAQV-REQUIMTE, Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Institute for Clinical and Biomedical Research (iCBR) Area of Environment Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0786-6280","authenticated-orcid":false,"given":"Filipa","family":"Mascarenhas-Melo","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"LAQV-REQUIMTE, Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"given":"In\u00eas","family":"Silva","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"given":"Ivana","family":"Jarak","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"given":"Francisco","family":"Veiga","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"LAQV-REQUIMTE, Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8170-1113","authenticated-orcid":false,"given":"Ana","family":"Figueiras","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"LAQV-REQUIMTE, Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sivakumar, B., and Deepthi, B. (2022). Complexity of COVID-19 dynamics. Entropy, 24.","DOI":"10.3390\/e24010050"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"112015","DOI":"10.1016\/j.biopha.2021.112015","article-title":"COVID-19 challenges and its therapeutics","volume":"142","author":"Rehman","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102589","DOI":"10.1016\/j.jddst.2021.102589","article-title":"Cyclodextrins in the Antiviral Therapy","volume":"64","author":"Jicsinszky","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2174\/1389450121666200615150039","article-title":"Characteristic of Cyclodextrins: Their Role and Use in the Pharmaceutical Technology","volume":"21","author":"Lachowicz","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"ref_5","unstructured":"(2022, December 05). Global Market Insights Global Cyclodextrin Market Size, Share and Industry Analysis Report by Type (Alpha, Beta, Gamma) and Application (Pharmaceutical, Food & Beverage, Chemicals, Cosmetics & Personal Care), Regional Outlook, Competitive Market Share & Forecast, 2021\u20132027. Available online: https:\/\/www.gminsights.com\/industry-analysis\/global-cyclodextrin-market."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e12998","DOI":"10.1111\/sji.12998","article-title":"Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management","volume":"93","author":"Anka","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11596-021-2395-1","article-title":"A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics","volume":"41","author":"Forchette","year":"2021","journal-title":"Curr. Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acs.molpharmaceut.0c00608","article-title":"COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies","volume":"18","author":"Salian","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 Transmission and Pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coph.2021.11.002","article-title":"Treatments for COVID-19: Lessons from 2020 and new therapeutic options","volume":"62","author":"Salasc","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fmolb.2020.606393","article-title":"Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives","volume":"7","author":"Kotta","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"659577","DOI":"10.3389\/fphar.2021.659577","article-title":"Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021","volume":"12","author":"Alam","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"173643","DOI":"10.1016\/j.ejphar.2020.173643","article-title":"Pharmacological insight into potential therapeutic agents for the deadly COVID-19 pandemic","volume":"890","author":"Bhandari","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3389\/fphys.2020.612268","article-title":"The Impact of Polyphenols-Based Diet on the Inflammatory Profile in COVID-19 Elderly and Obese Patients","volume":"11","author":"Santos","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Alanagreh, L., Alzoughool, F., and Atoum, M. (2020). The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms. Pathogens, 9.","DOI":"10.3390\/pathogens9050331"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jcph.1822","article-title":"Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review","volume":"61","author":"Khani","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e00399-20","DOI":"10.1128\/AAC.00399-20","article-title":"Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus Miguel","volume":"64","author":"Angel","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_21","first-page":"387","article-title":"Antiviral therapy for COVID-2019","volume":"25","author":"Hidayati","year":"2021","journal-title":"Anaesth. Pain Intensive Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3892\/etm.2021.10080","article-title":"Efficiency of antiviral treatment in COVID-19","volume":"21","author":"Negrut","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10238-020-00671-y","article-title":"Emerging treatment strategies for COVID-19 infection","volume":"21","author":"Gavriatopoulou","year":"2021","journal-title":"Clin. Exp. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3389\/fmed.2021.641429","article-title":"The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis","volume":"8","author":"Cao","year":"2021","journal-title":"Front. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00109-21","DOI":"10.1128\/CMR.00109-21","article-title":"SARS-CoV-2 Antiviral Therapy","volume":"34","author":"Tao","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","article-title":"A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2","volume":"369","author":"Chi","year":"2020","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing monoclonal antibodies for treatment of COVID-19","volume":"21","author":"Taylor","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41590-022-01138-w","article-title":"An engineered bispecific human monoclonal antibody against SARS-CoV-2","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMe2205563","article-title":"Monoclonal Antibodies with Extended Half-Life to Prevent COVID-19","volume":"386","author":"Abraham","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jmv.27317","article-title":"The role of type I interferon in the treatment of COVID-19","volume":"94","author":"Sodeifian","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"21291","DOI":"10.1038\/s41598-020-78039-1","article-title":"Viral clearance after early corticosteroid treatment in patients with moderate or severe COVID-19","volume":"10","author":"Spagnuolo","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between Administration of Systemic Corticosteroids and Mortality among Critically Ill Patients with COVID-19: A Meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41591-021-01643-9","article-title":"A guide to immunotherapy for COVID-19","volume":"28","author":"Pickkers","year":"2022","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lee, J.U., Lee, S.S., Lee, S., and Oh, H. (2020). Bin Noncovalent complexes of cyclodextrin with small organic molecules: Applications and insights into host\u2013guest interactions in the gas phase and condensed phase. Molecules, 25.","DOI":"10.3390\/molecules25184048"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fchem.2021.658548","article-title":"Applications of Macrocyclic Host Molecules in Immune Modulation and Therapeutic Delivery","volume":"9","author":"Soni","year":"2021","journal-title":"Front. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"119689","DOI":"10.1016\/j.ijpharm.2020.119689","article-title":"The Lord of the NanoRings: Cyclodextrins and the battle against SARS-CoV-2","volume":"588","author":"Garrido","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chaves, O.A., Sacramento, C.Q., Ferreira, A.C., Mattos, M., Fintelman-Rodrigues, N., Temerozo, J.R., Vazquez, L., Pinto, D.P., da Silveira, G.P.E., and da Fonseca, L.B. (2021). Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo. Pharmaceuticals, 15.","DOI":"10.3390\/ph15010021"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/cts.13292","article-title":"PF-07321332 (Nirmatrelvir) does not interact with human ENT1 or ENT2: Implications for COVID-19 patients","volume":"15","author":"Hau","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","article-title":"Role of favipiravir in the treatment of COVID-19","volume":"102","author":"Joshi","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"\u0141agocka, R., Dziedziejko, V., K\u0142os, P., and Pawlik, A. (2021). Favipiravir in therapy of viral infections. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020273"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Braga, S.S., Barbosa, J.S., Santos, N.E., El-Saleh, F., and Paz, F.A.A. (2021). Cyclodextrins in antiviral therapeutics and vaccines. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13030409"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"114482","DOI":"10.1016\/j.jpba.2021.114482","article-title":"Molecular interactions in remdesivir-cyclodextrin systems","volume":"209","author":"Malanga","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"118011","DOI":"10.1016\/j.carbpol.2021.118011","article-title":"Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun- and lyophilized formulations","volume":"264","author":"Szente","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"117157","DOI":"10.1016\/j.molliq.2021.117157","article-title":"Remdesivir interactions with sulphobutylether-\u03b2-cyclodextrins: A case study using selected substitution patterns","volume":"346","author":"Pipkin","year":"2022","journal-title":"J. Mol. Liq."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"117588","DOI":"10.1016\/j.molliq.2021.117588","article-title":"Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulphobutylether-\u03b2-cyclodextrins and remdesivir","volume":"343","author":"Pipkin","year":"2021","journal-title":"J. Mol. Liq."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1681\/ASN.2020050589","article-title":"Remdesivir in patients with acute or chronic kidney disease and COVID-19","volume":"31","author":"Adamsick","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_51","unstructured":"Gilead Sciences Inc. (2023, January 23). A Phase 2\/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734TM) in Participants from Birth to <18 Years of Age with COVID-19, Available online: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04431453."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"173854","DOI":"10.1016\/j.ejphar.2021.173854","article-title":"Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic","volume":"894","author":"Noreen","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Belhocine, Y., Rahali, S., Allal, H., Assaba, I.M., Ghoniem, M.G., and Ali, F.A.M. (2021). A dispersion corrected DFT investigation of the inclusion complexation of dexamethasone with \u03b2-cyclodextrin and molecular docking study of its potential activity against COVID-19. Molecules, 26.","DOI":"10.3390\/molecules26247622"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The pharmacokinetics and interactions of ivermectin in humans\u2014A mini-review","volume":"10","author":"Canga","year":"2008","journal-title":"AAPS J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-4690-6-112","article-title":"Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal","volume":"6","author":"Levin","year":"2009","journal-title":"Retrovirology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e12953","DOI":"10.1111\/cmi.12953","article-title":"Molecular dissection of an inhibitor targeting the HIV integrase dependent preintegration complex nuclear import","volume":"21","author":"Wagstaff","year":"2019","journal-title":"Cell. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Cruciani, M., Pati, I., Masiello, F., Malena, M., Pupella, S., and De Angelis, V. (2021). Ivermectin for prophylaxis and treatment of COVID-19: A systematic review and meta-analysis. Diagnostics, 11.","DOI":"10.3390\/diagnostics11091645"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1016\/j.mjafi.2021.06.002","article-title":"Ivermectin as a multifaceted drug in COVID-19: Current insights","volume":"77","author":"Khandelwal","year":"2021","journal-title":"Med. J. Armed Forces India"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"108004","DOI":"10.1016\/j.intimp.2021.108004","article-title":"Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study","volume":"99","author":"Mansour","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3947\/ic.2021.0028","article-title":"Effects of interferon beta in COVID-19 adult patients: Systematic review","volume":"53","author":"Sosa","year":"2021","journal-title":"Infect. Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jconrel.2020.11.019","article-title":"Intranasal delivery of interferon- \u03b2-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy","volume":"331","author":"Acu","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"115287","DOI":"10.1016\/j.carbpol.2019.115287","article-title":"Cyclodextrin solubilization and complexation of antiretroviral drug lopinavir: In silico prediction; Effects of derivatization, molar ratio and preparation method","volume":"227","author":"Adeoye","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200363080-00004","article-title":"Lopinavir\/ritonavir: A review of its use in the management of HIV infection","volume":"63","author":"Cvetkovic","year":"2003","journal-title":"Drugs"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jiph.2021.03.015","article-title":"Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials","volume":"14","author":"Patel","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"119356","DOI":"10.1016\/j.ijpharm.2020.119356","article-title":"Pyromellitic dianhydride crosslinked soluble cyclodextrin polymers: Synthesis, lopinavir release from sub-micron sized particles and anti-HIV-1 activity","volume":"583","author":"Adeoye","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"115057","DOI":"10.1016\/j.jpba.2022.115057","article-title":"A novel and water-soluble material for coronavirus inactivation from oseltamivir in the cavity of methyl and sulfated-\u03b2-cyclodextrins through inclusion complexation","volume":"221","author":"Rajamohan","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/japtr.japtr_33_22","article-title":"Innovated formulation of oseltamivir powder for suspension with stability study after reconstitution using a developed ion-pair reversed phase high-performance liquid chromatography method","volume":"13","author":"Hasson","year":"2022","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"(2021). Deepak Gunwal; Braham Dutt; Manjusha Choudhary; Vikas Budhwar A Comprehensive Review on the Drug: Fenofibrate. Int. J. Res. Pharm. Sci., 12, 2164\u20132172.","DOI":"10.26452\/ijrps.v12i3.4829"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"100148","DOI":"10.1016\/j.rechem.2021.100148","article-title":"Molecular basis of quercetin as a plausible common denominator of macrophage-cholesterol-fenofibrate dependent potential COVID-19 treatment axis","volume":"3","author":"Pawar","year":"2021","journal-title":"Results Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/s42255-022-00698-3","article-title":"A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019","volume":"4","author":"Chirinos","year":"2022","journal-title":"Nat. Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4274\/tjps.60490","article-title":"Enhancement of dissolution of fenofibrate using complexation with hydroxy propyl \u03b2-cyclodextrin","volume":"16","author":"Jagdale","year":"2019","journal-title":"Turk. J. Pharm. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4067\/S0718-381X2021000100027","article-title":"Cetylpyridinium Chloride as a Tool Against COVID-19","volume":"15","year":"2021","journal-title":"Int. J. Odontostomatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ajoms.2022.04.001","article-title":"Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2","volume":"34","author":"Okamoto","year":"2022","journal-title":"J. Oral Maxillofac. Surg. Med. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajoms.2021.09.007","article-title":"Cetylpyridinium chloride mouthwashes: Potential role in COVID-19 control","volume":"34","author":"Carruitero","year":"2022","journal-title":"J. Oral Maxillofac. Surg. Med. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Hano, C., and Tungmunnithum, D. (2020). Plant Polyphenols, More than Just Simple Natural Antioxidants: Oxidative Stress, Aging and Age-Related Diseases. Medicines, 7.","DOI":"10.3390\/medicines7050026"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e2012201118","DOI":"10.1073\/pnas.2012201118","article-title":"Bepridil is potent against SARS-CoV-2 in vitro","volume":"118","author":"Vatansever","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","article-title":"BDDCS Applied to Over 900 Drugs","volume":"13","author":"Benet","year":"2011","journal-title":"AAPS J."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Wahab, S., Annadurai, S., Abullais, S.S., Das, G., Ahmad, W., Ahmad, M.F., Kandasamy, G., Vasudevan, R., Ali, M.S., and Amir, M. (2021). Glycyrrhiza glabra (Licorice): A comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology. Plants, 10.","DOI":"10.3390\/plants10122751"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.2174\/1389557521666210210160237","article-title":"Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19)","volume":"21","author":"Grundmann","year":"2021","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"20995","DOI":"10.1021\/acsami.1c02755","article-title":"Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment","volume":"13","author":"Zhao","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10847-016-0626-z","article-title":"Molecular dynamics simulations of inclusion complexation of glycyrrhizic acid and cyclodextrins (1:1) in water","volume":"85","author":"Oda","year":"2016","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejmech.2019.01.074","article-title":"Synthesis and structure-activity relationship studies of water-soluble \u03b2-cyclodextrin-glycyrrhetinic acid conjugates as potential anti-influenza virus agents","volume":"166","author":"Liang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/DDDT.S94165","article-title":"Plitidepsin: Design, development, and potential place in therapy","volume":"11","author":"Pardal","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e00200-21","DOI":"10.1128\/AAC.00200-21","article-title":"Plitidepsin: A Repurposed Drug for the Treatment of COVID-19","volume":"65","author":"Martinez","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.abf4058","article-title":"Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A","volume":"371","author":"White","year":"2021","journal-title":"Science"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Papapanou, M., Papoutsi, E., Giannakas, T., and Katsaounou, P. (2021). Plitidepsin: Mechanisms and clinical profile of a promising antiviral agent against COVID-19. J. Pers. Med., 11.","DOI":"10.3390\/jpm11070668"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e202101200","DOI":"10.26508\/lsa.202101200","article-title":"Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19","volume":"5","author":"Varona","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11095-013-1220-3","article-title":"Nano-encapsulation of plitidepsin: In vivo pharmacokinetics, biodistribution, and efficacy in a renal xenograft tumor model","volume":"31","author":"Oliveira","year":"2014","journal-title":"Pharm. Res."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Jaskulska, A., Janecka, A.E., and Gach-Janczak, K. (2021). Thapsigargin\u2014From traditional medicine to anticancer drug. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010004"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Goulding, L.V., Yang, J., Jiang, Z., Zhang, H., Lea, D., Emes, R.D., Dottorini, T., Pu, J., Liu, J., and Chang, K.C. (2020). Thapsigargin at non-cytotoxic levels induces a potent host antiviral response that blocks influenza a virus replication. Viruses, 12.","DOI":"10.3390\/v12101093"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2022.04.004","article-title":"Thapsigargin: Key to new host-directed coronavirus antivirals?","volume":"43","author":"Shaban","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Al-Beltagi, S., Preda, C.A., Goulding, L.V., James, J., Pu, J., Skinner, P., Jiang, Z., Wang, B.L., Yang, J., and Banyard, A.C. (2021). Thapsigargin is a broad-spectrum inhibitor of major human respiratory viruses: Coronavirus, respiratory syncytial virus and influenza a virus. Viruses, 13.","DOI":"10.3390\/v13020234"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.18632\/aging.102437","article-title":"Promising therapeutic effect of thapsigargin nanoparticles on chronic kidney disease through the activation of Nrf2 and FoxO1","volume":"11","author":"Cheng","year":"2019","journal-title":"Aging"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bioactmat.2020.05.002","article-title":"A review of the application of nanoparticles in the diagnosis and treatment of chronic kidney disease","volume":"5","author":"Ma","year":"2020","journal-title":"Bioact. Mater."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1134\/S1607672917020028","article-title":"Methyl-\u03b2-cyclodextrin modulates thapsigargin-induced store-dependent Ca2+ entry in macrophages","volume":"473","author":"Krutetskaya","year":"2017","journal-title":"Dokl. Biochem. Biophys."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Amawi, H., Ashby, C.R., Samuel, T., Peraman, R., and Tiwari, A.K. (2017). Polyphenolic nutrients in cancer chemoprevention and metastasis: Role of the epithelial-to-mesenchymal (EMT) pathway. Nutrients, 9.","DOI":"10.3390\/nu9080911"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fnut.2018.00087","article-title":"The Role of Polyphenols in Human Health and Food Systems: A Mini-Review","volume":"5","author":"Cory","year":"2018","journal-title":"Front. Nutr."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Li, X., Sang, S., McClements, D.J., Chen, L., Long, J., Jiao, A., Jin, Z., and Qiu, C. (2022). Polyphenols as Plant-Based Nutraceuticals: Health Effects, Encapsulation, Nano-Delivery, and Application. Foods, 11.","DOI":"10.3390\/foods11152189"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejpb.2021.02.003","article-title":"Polyphenols against infectious diseases: Controlled release nano-formulations","volume":"161","author":"Agrahari","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"149719","DOI":"10.1016\/j.scitotenv.2021.149719","article-title":"Polyphenols and their potential role to fight viral diseases: An overview","volume":"801","author":"Vecino","year":"2021","journal-title":"Sci. Total Environ."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11101-021-09759-z","article-title":"Flavonoids are promising safe therapy against COVID-19","volume":"21","author":"Alzaabi","year":"2022","journal-title":"Phytochem. Rev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1080\/07391102.2020.1779818","article-title":"Evaluation of green tea polyphenols as novel corona virus (SARS-CoV-2) main protease (Mpro) inhibitors\u2013an in silico docking and molecular dynamics simulation study","volume":"39","author":"Ghosh","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1080\/07391102.2020.1802347","article-title":"Identification of polyphenols from Broussonetia papyrifera as SARS-CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches","volume":"39","author":"Ghosh","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"bap024","DOI":"10.1093\/database\/bap024","article-title":"Phenol-Explorer: An online comprehensive database on polyphenol contents in foods","volume":"2010","author":"Neveu","year":"2010","journal-title":"Database"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1016\/j.csbj.2021.09.022","article-title":"Polyphenols as alternative treatments of COVID-19","volume":"19","author":"Wu","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Milin\u010di\u0107, D.D., Popovi\u0107, D.A., Levi\u0107, S.M., Kosti\u0107, A., Te\u0161i\u0107, \u017d.L., Nedovi\u0107, V.A., and Pe\u0161i\u0107, M.B. (2019). Application of polyphenol-loaded nanoparticles in food industry. Nanomaterials, 9.","DOI":"10.3390\/nano9111629"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e23084","DOI":"10.1002\/bip.23084","article-title":"\u03b2-cyclodextrin encapsulated polyphenols as effective antioxidants","volume":"109","author":"Roy","year":"2018","journal-title":"Biopolymers"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbapap.2017.02.014","article-title":"Polyphenols in combination with \u03b2-cyclodextrin can inhibit and disaggregate \u03b1-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative","volume":"1865","author":"Gautam","year":"2017","journal-title":"Biochim. Biophys. Acta-Proteins Proteom."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"122028","DOI":"10.1016\/j.ijpharm.2022.122028","article-title":"Improved ocular delivery of quercetin and resveratrol: A comparative study between binary and ternary cyclodextrin complexes","volume":"624","author":"Jarho","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Romero, A.M., Maestrelli, F., Garc\u00eda-Gil, S., Talero, E., Mura, P., Rabasco, A.M., and Gonz\u00e1lez-Rodr\u00edguez, M.L. (2021). Preparation, characterization and evaluation of the anti-inflammatory activity of epichlorohydrin-\u03b2-cyclodextrin\/curcumin binary systems embedded in a pluronic\u00ae\/hyaluronate hydrogel. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413566"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"107844","DOI":"10.1016\/j.biotechadv.2021.107844","article-title":"Resveratrol and cyclodextrins, an easy alliance: Applications in nanomedicine, green chemistry and biotechnology","volume":"53","author":"Jeandet","year":"2021","journal-title":"Biotechnol. Adv."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Gligorijevi\u0107, N., Stani\u0107-Vu\u010dini\u0107, D., Radomirovi\u0107, M., Stojadinovi\u0107, M., Khulal, U., Nedi\u0107, O., and \u0106irkovi\u0107 Veli\u010dkovi\u0107, T. (2021). Role of resveratrol in prevention and control of cardiovascular disorders and cardiovascular complications related to COVID-19 disease: Mode of action and approaches explored to increase its bioavailability. Molecules, 26.","DOI":"10.20944\/preprints202103.0419.v1"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1021\/acs.jafc.5b00672","article-title":"\u03b2-Cyclodextrin-Assisted Extraction of Polyphenols from Vine Shoot Cultivars","volume":"63","author":"Rajha","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s00217-021-03839-2","article-title":"Cyclodextrins as high-performance green co-solvents in the aqueous extraction of polyphenols and anthocyanin pigments from solid onion waste","volume":"247","author":"Bozinou","year":"2021","journal-title":"Eur. Food Res. Technol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/oxygen2040029","article-title":"\u03b2-Cyclodextrin-Aided Aqueous Extraction of Antioxidant Polyphenols from Peppermint (Mentha \u00d7 piperita L.)","volume":"2","author":"Athanasiadis","year":"2022","journal-title":"Oxygen"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2174\/1381612824666171218125431","article-title":"Cyclodextrins as Drug Carriers in Pharmaceutical Technology: The State of the Art","volume":"24","author":"Conceicao","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Braga, S.S. (2019). Cyclodextrins: Emerging medicines of the new millennium. Biomolecules, 9.","DOI":"10.3390\/biom9120801"},{"key":"ref_118","unstructured":"Committee for Human Medicinal Products (CHMP) (2007). Background Review for Cyclodextrins Used as Excipients, European Medicines Agency."},{"key":"ref_119","unstructured":"Committee for Human Medicinal Products (CHMP) (2007). Questions and Answers on Cyclodextrins Used as Excipients in Medicinal Products for Human Use, European Medicines Agency."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejpb.2022.07.007","article-title":"Cyclodextrin-based delivery systems in parenteral formulations: A critical update review","volume":"178","author":"Ferreira","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tifs.2020.08.009","article-title":"Applications of cyclodextrins in food science. A review","volume":"104","author":"Matencio","year":"2020","journal-title":"Trends Food Sci. Technol."},{"key":"ref_122","unstructured":"Chalmers, J. (2023, January 23). A Randomised, Double-Blind, Placebo-Controlled Trial of SFX-01 or Placebo on a Backbone of Best Standard Care, to Improve Outcomes in Patients with Community Acquired Pneumonia and Suspected or Confirmed SARS-CoV-2 Infection. Available online: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-003486-19\/GB."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Raman, R., Patel, K.J., and Ranjan, K. (2021). COVID-19: Unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies. Biomolecules, 11.","DOI":"10.20944\/preprints202106.0060.v1"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Boroushaki, T., and Dekamin, M.G. (2022). Interactions between \u03b2-cyclodextrin as a carrier for anti-cancer drug delivery: A molecular dynamics simulation study. J. Biomol. Struct. Dyn.","DOI":"10.1080\/07391102.2022.2164058"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1111\/1750-3841.16303","article-title":"Formation and molecular dynamics simulation of inclusion complex of large-ring cyclodextrin and 4-terpineol","volume":"87","author":"Cao","year":"2022","journal-title":"J. Food Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2100305","DOI":"10.1002\/masy.202100305","article-title":"Inclusion Complexes Between \u03b2-cyclodextrin and the Anticancer Drug 5-Fluorouracil for its Solubilization: A Molecular Dynamics Study at Different Stoichiometries","volume":"404","author":"Raffaini","year":"2022","journal-title":"Macromol. Symp."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2974\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:23:06Z","timestamp":1760120586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":126,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032974"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032974","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}